Telephone-based Hopkins Verbal Learning Test-Revised as a pre-screening tool for identifying SuperAgers.
Telephone-based Hopkins Verbal Learning Test-Revised as a pre-screening tool for identifying SuperAgers. Arch Clin Neuropsychol. 2026 Sep 09; 41(7).
PMID: 42715377
Lessons From the Communication Bridge Trials: Advancing Meaningful Dyadic Interventions Toward Implementation.
Lessons From the Communication Bridge Trials: Advancing Meaningful Dyadic Interventions Toward Implementation. J Speech Lang Hear Res. 2026 Sep 08; 1-10.
PMID: 42709848
Psychological well-being in cognitively intact adults aged 80+: Findings from the SuperAging Research Initiative.
Psychological well-being in cognitively intact adults aged 80+: Findings from the SuperAging Research Initiative. Front Psychol. 2026; 17:1819539.
PMID: 42718493
EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.
EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker. Neurology. 2026 Oct 13; 107(7):e218519.
PMID: 42647766
SuperAging is not the inverse of common-variant Alzheimer's risk: evidence across genetic ancestries.
SuperAging is not the inverse of common-variant Alzheimer's risk: evidence across genetic ancestries. Alzheimers Res Ther. 2026 Jul 23; 18(1).
PMID: 42493810
Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease.
Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease. Alzheimers Dement. 2026 Jul; 22(7):e71479.
PMID: 42477860
Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial.
Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial. Alzheimers Dement (N Y). 2026 Apr-Jun; 12(2):e70283.
PMID: 42358427
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease. Brain Commun. 2026; 8(3):fcag176.
PMID: 42255923
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS. Alzheimers Dement (Amst). 2026 Apr-Jun; 18:e70342.
PMID: 42088846
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS. Alzheimers Dement. 2026 May; 22(5):e71492.
PMID: 42151732